Studies Confirm Direct Oral Challenge Safely Delabels Penicillin Allergies in Hospitals
Studies show direct oral challenge safely removes penicillin allergies in hospitals, increasing penicillin use 13-fold within 90 days.
Read MoreALL ABOUT DAILYZ HEALTH NEWS
ALL ABOUT DAILYZ HEALTH NEWS
Studies show direct oral challenge safely removes penicillin allergies in hospitals, increasing penicillin use 13-fold within 90 days.
Read MoreA study finds stopping Ozempic or Wegovy for six months or more reverses cardiovascular benefits in type 2 diabetes patients.
Read MoreA UK Biobank study found that highest physical activity levels reduce risk of 13 cancer types by 26%, based on accelerometer data.
Read MoreThe FDA approved Novo Nordisk’s 25 mg oral Wegovy semaglutide tablet for adult weight management, launching in January 2026.
Read MoreResearchers developed a DNA-based drug that activates only in cancer cells expressing two tumor markers, improving targeted treatment precision.
Read MoreA Stanford trial found a five-day monthly fasting-mimicking diet improved symptoms and remission in 69% of Crohn’s disease patients.
Read MoreA UCSF study finds aging lung cells trigger harmful immune overreactions to flu and COVID-19 in older adults, worsening lung damage.
Read MoreThe FDA set an April 23, 2026 PDUFA date for subcutaneous isatuximab in relapsed/refractory multiple myeloma, following positive phase 3 trial results.
Read MorePope Leo XIV’s decision to carry the full wooden cross through all 14 Stations at Rome’s Colosseum drew renewed attention to the connection between physical acts of religious devotion and spiritual wellness.
Read MoreA VA study found type 2 diabetes patients stopping GLP-1 drugs regained weight and faced a 22% rise in cardiovascular risks.
Read More